These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Role of calcium antagonists in systemic hypertension. Zanchetti A Am J Cardiol; 1987 Jan; 59(3):130B-136B. PubMed ID: 2880494 [TBL] [Abstract][Full Text] [Related]
36. Renal effects of felodipine in hypertension. Leonetti G; Terzoli L; Rupoli L; Gradnik R; Zanchetti A Drugs; 1987; 34 Suppl 3():59-66. PubMed ID: 3443065 [TBL] [Abstract][Full Text] [Related]
37. The natriuresis following oral administration of the calcium antagonists--nifedipine and nitrendipine. Ene MD; Williamson PJ; Roberts CJ; Waddell G Br J Clin Pharmacol; 1985 Apr; 19(4):423-7. PubMed ID: 3158325 [TBL] [Abstract][Full Text] [Related]
38. Modification of the renal effects of ouabain by calcium channel blockers. Cruz-Soto MA; MartÃnez-Maldonado M Adv Exp Med Biol; 1984; 178():319-27. PubMed ID: 6391100 [No Abstract] [Full Text] [Related]
39. The role of the kidney in hypertension. Cowley AW; Roman RJ JAMA; 1996 May 22-29; 275(20):1581-9. PubMed ID: 8622250 [No Abstract] [Full Text] [Related]
40. [The role of new dihydropyridine calcium channel blockers in the treatment of hypertension]. Coca A An Med Interna; 2003 Jun; 20(6):279-81. PubMed ID: 12848596 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]